Association between the type of thyroid dysfunction induced by immune checkpoint inhibitors and prognosis in cancer patients.

It was verified that ICI treatment-induced thyroid dysfunction was associated with better survival, even in the real-world practice. Thus, endocrinologists should cooperate with oncologists to monitor patients treated with ICIs.